Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 2017 Jun 23;55(7):2255–2260. doi: 10.1128/JCM.00377-17

Comparison of the Vitek MS and Bruker Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry Systems for Identification of Rhodococcus equi and Dietzia spp.

Carlos Ruiz de Alegría Puig a,, Lilian Pilares b, Francesc Marco c, Jordi Vila c, Luis Martínez-Martínez a, Jesús Navas b
Editor: Karen C Carrolld
PMCID: PMC5483928  PMID: 28490491

ABSTRACT

Rhodococcus equi causes pyogranulomatous pneumonia in domesticated animals and immunocompromised humans. Dietzia spp. are environmental bacteria that have rarely been associated with human infections. R. equi and Dietzia spp. are closely related actinomycetes. Phenotypic discrimination between R. equi and Dietzia on the basis of their Gram stain morphology and colony appearance is problematic. Matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) is a fast, reliable, and cost-effective method for identification of a wide variety of microorganisms. We have evaluated the performance of Bruker Biotyper versus that of Vitek MS for identification of a collection of 154 isolates identified at the source as R. equi that includes isolates belonging to the genus Dietzia. PCR amplification of the choE gene, encoding a cholesterol oxidase, and 16S rRNA sequencing were considered the reference methods for R. equi identification. Biotyper identified 131 (85.1%) of the 154 isolates at the species level, and this figure increased to 152 (98.7%) when the species cutoff was reduced from a score of ≥2.000 to ≥1.750. Vitek MS correctly identified at the species level 130 (84.4%) isolates as long as bacteria were extracted with ethanol but only 35 (22.7%) isolates when samples were prepared by direct extraction from colonies. The two systems allowed differentiation between R. equi and Dietzia spp., but identification of all Dietzia sp. isolates at the species level needed sequencing of the 16S rRNA gene.

KEYWORDS: Rhodococcus equi, Dietzia spp., identification, MALDI-TOF MS, genotypic identification

INTRODUCTION

The soil-dwelling, saprophytic actinomycete Rhodococcus equi is a multihost, facultative intracellular pathogen that causes pyogranulomatous infections in several species of domesticated animals, in particular, in young foals and pigs (1). In addition, R. equi infects humans (2). At-risk groups are immunocompromised people, such as HIV-AIDS or cancer patients, and transplant recipients. Infection with R. equi in these patients results in a granulomatous form of pneumonia whose symptoms resemble clinical and pathological signs of pulmonary tuberculosis and which has a high mortality rate. Dietzia spp. are environmental bacteria that have been associated with human infections in a small number of cases (3). The Gram morphology and colony appearance of the species of the genus Dietzia are remarkably similar to those seen with R. equi.

In clinical microbiology laboratories, R. equi is routinely identified using a conventional approach based on growth characteristics, morphology of colonies, the CAMP reaction, and biochemical tests, which are frequently performed using the API Coryne system (bio-Mérieux, Marcy l'Etoile, France), a commercial multisubstrate kit that includes R. equi in its database (4). However, this method is time-consuming and its reliability for the identification of rhodococcal isolates is low, resulting in misidentification of R. equi as another rhodococcal species or even another actinomycetes (5). For instance, Bemer-Melchior et al. (6) reported that API Coryne V2.0 gave an identification of R. equi for a Dietzia maris isolate obtained from an immunocompromised patient. Our group (7) and other authors (8) have also reported the misidentification of Dietzia strains as R. equi. PCR methods targeting the R. equi choE gene, encoding a cholesterol oxidase, are accurate and reliable, allowing identification of R. equi isolated from human, animal, or environmental samples (9, 10).

Matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) is a fast, highly accurate, and cost-effective method for identification of bacterial and fungal pathogens (11). The MALDI Biotyper (Bruker Daltonics GmbH, Bremen, Germany) and the Vitek MS (bioMérieux) platforms are the two MS-based platforms more commonly used for microbial identification. In a previous study (12), we reported that the Bruker MS system identified successfully at the species level a group of 11 isolates initially assigned to R. equi by API Coryne V2.0, confirming identification of all isolates as R. equi except 1, which was classified as Dietzia maris. Although limited to a few isolates, that study envisaged that MALDI-TOF MS might represent an alternative, fast, and worthwhile method for a reliable identification of R. equi and Dietzia spp.

In the present study, we carried out a comparative evaluation of the performance of Vitek MS versus that of Bruker Biotyper for identification of a panel of 154 isolates initially assigned to R. equi by API Coryne V2.0 that included isolates belonging to the genus Dietzia.

RESULTS

A total of 144 of the 154 isolates were positive in the PCR amplification assay targeting the choE and therefore were assigned to R. equi. The remaining 10 isolates gave a negative choE PCR result. By partial 16S rRNA sequencing, they were identified as Dietzia maris (n = 5), Dietzia natronolimmnaea (n = 3), and Dietzia cinnamea (n = 2). This identification was considered the reference method.

In direct testing of bacterial colonies with Vitek MS, the system correctly identified 35 (22.7%) isolates at the species level at its best performance. In most cases, failure of the system to give a precise identification was due to its inability to read the samples. When bacteria were extracted with ethanol, Vitek MS correctly identified at the species level a total of 130 (84.4%) isolates: 124 were identified as R. equi and 6 as Dietzia spp. (Table 1). Within the collection of 144 R. equi isolates, Vitek MS properly identified 124 (86.1%) isolates with the maximum score (99.9%). When the confidence score was decreased to 50%, an additional isolate was correctly identified as R. equi as well. Considering the group of 10 Dietzia sp. isolates, Vitek MS identified 6 (60%) strains with the maximum score (99.9%) and 2 (20%) strains (D. natronolimnaea and D. maris) with a score of 50%, whereas the remaining 2 strains (D. natronolimnaea and D. cinnamea) were not identified (Table 2).

TABLE 1.

Comparison of the identification results for the 154 isolates with the Vitek MS and the Biotyper MALDI-TOF MS systems using two different methods for the preparation of the samplesa

MALDI-TOF MS system No. of isolates identified by:
Direct colony method
Extraction method
Total R. equi Dietzia spp. Not identified Total R. equi Dietzia spp. Not identified
Vitek MS 35 35 0 119 130 (35 + 95*) 124 (35 + 89*) 6 (0 + 6*) 24
Bruker Biotyper 141 141 0 13 153 (141 + 12*) 144 (141 + 3*) 9 (0 + 9*) 1
a

*, the number of strains which required sample extraction to give a reliable identification.

TABLE 2.

Identification results for R. equi (n = 144) and Dietzia spp. (n = 10) by Vitek MS versus Bruker Biotyper

Microorganism(s) No. of strains No. (%) of isolates with indicated result by:
Vitek MS
Bruker Biotyper
Correct identification at species level Correct low score (50%–99.8%) Not identified Identification at genus level Correct identification at species level Correct low score (1.7–2) Not identified Identification at genus level
R. equi 144 124 (86.1) 1 (0.7) 19 (13.2) 0 130 (90.3) 14 (9.7) 0 0
Dietzia spp. 10 6 (60) 2 (20) 2 (20) 0 1 (10) 7 (70) 1 (10) 1 (10)
    D. maris 5 4 1 0 0 1 4 0 0
    D. natronolimnaea 3 1 1 1 0 0 3 0 0
    D. cinnamea 2 1 0 1 0 0 0 1 1
Total no. (%) of strains 154 130 (84.4) 3 (1.9) 21 (13.6) 0 131 (85.1) 21 (13.6) 1 (0.6) 1 (0.6)

The Biotyper provided high-confidence identifications without extraction of the samples for 141 (91.6%) isolates. Conversely, a group of 13 isolates, including the 10 Dietzia sp. isolates and 3 R. equi isolates, required acetonitrile extraction (Table 1). The system correctly identified at the species level 131 (85%) isolates (130 R. equi and 1 Dietzia sp.), giving scores of ≥2.000 in all cases. The 130 isolates identified as R. equi were positive for PCR choE, whereas the isolate identified as a Dietzia sp. was negative. The remaining R. equi isolates (n = 14), giving scores in the range of 1.700 to 1.900, were reanalyzed using a species-level cutoff value of ≥1.750. With the ≥1.750 score cutoff, all 14 of these isolates were also identified as R. equi, in accordance with the results of PCR amplification of the choE gene (all were positive). Considering the group of 10 Dietzia sp. isolates, the Biotyper identified 1 (10%) strain (score, ≥2.000) at the species level and 8 (80%) strains at the genus level (scores ranged between 1.700 and 1.999) and another 1 (10%) could not be identified (score, <1.700). When the species level cutoff value was lowered to a score of ≥1.750, 7 of 8 Dietzia spp. were also correctly identified at the species level, as subsequently confirmed by 16S rRNA sequencing (Table 2).

DISCUSSION

Identification of R. equi by conventional methods based on colony morphology, growth properties, or biochemical profiles is not reliable and requires molecular methods to differentiate it from Dietzia spp. MALDI-TOF MS is a fast method for identification of microorganisms of clinical interest and could be an adequate option in considering R. equi and Dietzia spp. In routine diagnostics, MALDI-TOF MS has advantages with respect to the time and effort needed to obtain identification results at the species level. However, there is little information on the performance of the two main commercially available MALDI-TOF MS systems for the identification of these two closely related actinomycetes.

Overall, with the direct colony extraction method, the Biotyper permitted the identification of 91.6% of the strains tested, in contrast to only 22.7% for Vitek MS. For the Biotyper system, previous studies have reported improved species-level identification rates without an increase in the false-identification rates for a variety of different organisms by decreasing the identification score either to 1.900 (13) or to 1.700 (14). By lowering the score representing species-level identification from ≥2.000 to ≥1.750, we were able to identify at the species level practically all the strains tested in this study, 144 (100%) R. equi strains and 8 (80%) of 10 Dietzia sp. strains, without any misidentification. Only one strain gave a score lower than 1.700 and therefore could not be identified with the Biotyper MS. This strain was identified as D. cinnamea by 16S rRNA sequencing. D. cinnamea was first isolated from a perianal swab of a patient with a bone marrow transplant (15), but it is mostly known for its ability to degrade a wide variety of organic compounds and rarely for its pathogenic potential (16). The performance of the Biotyper in identification of R. equi, distinguishing it from Dietzia spp., is comparable to the performances of PCR choE and 16S rRNA sequencing. When the species cutoff value was reduced to a score of ≥1.750, Biotyper correctly identified all the R. equi isolates. PCR choE analysis is a reliable method for R. equi identification, but MALDI-TOF MS is faster and more economical in terms of both labor and monetary cost. Although Dietzia spp. are not commonly associated with human infections, sporadic cases necessitate accurate identification of Dietzia spp. at the species level. 16S rRNA sequencing is currently the only method that guarantees definitive and conclusive identification of Dietzia spp. to the rank of species.

The results obtained in this study indicate that for the Vitek MS system, pretreatment of bacterial colonies with ethanol improves substantially the number of correct identifications with the highest level of confidence. Actinomycetes such as R. equi and Dietzia spp. contain in their cell walls long-chain mycolic acids as well as a great amount of lipopolysaccharide, preventing the complete uptake of energy when fired upon by the laser. Consequently, mass spectra are not generated. With the use of ethanol in the extraction method, a substantial amount of mycolic acids and polysaccharide is eliminated, while the target proteins are preserved, allowing the generation of high-quality spectra (17). We consider that, with the extraction method, the Vitek MS system has performed properly, with an acceptable rate of 84.4% of samples correctly identified at the species level. However, it was not able to identify 20 R. equi isolates or to distinguish properly 4 Dietzia spp. from R. equi, while PCR choE analysis correctly identified all the R. equi isolates. The SARAMIS 2.0 database includes three species of the genus Dietzia: D. maris, D. natronolimnaea, and D. cinnamea. However, Vitek MS identified at the species level only 6 of the 10 Dietzia isolates analyzed. The genus Dietzia has been established recently, and only a few strains have been implicated in human infections (18).

Overall, in the comparisons of the two systems, the MALDI Biotyper system provided higher accuracy than the Vitek MS system for identification of R. equi as well as for differentiation of R. equi from Dietzia spp. Although the data were limited in that only 10 isolates were included in the study, the results indicated that proper identification of Dietzia spp. at the species level requires confirmation by 16S rRNA sequencing. Spectral databases should be regularly updated by suppliers to improve identification rates.

MATERIALS AND METHODS

Bacterial strains.

A total of 154 isolates, all originally identified as R. equi, were included in the study. A total of 129 of the 154 isolates were previously identified as R. equi by means of PCR amplification of the choE gene, encoding a R. equi cholesterol oxidase (9). Eight of the 154 isolates were negative for the PCR choE gene and were identified as members of the genus Dietzia by 16S rRNA sequencing (7). The remaining 17 isolates (15 R. equi isolates and 2 Dietzia sp. isolates) were submitted to the clinical microbiology laboratory of Marqués de Valdecilla university hospital during the period 2010 to 2014. The collection included strains isolated from AIDS patients at different Spanish hospitals (n = 71), isolates from pneumonic foals (n = 34), and strains isolated from soil samples collected from the environment (n = 49). They were grown on Columbia horse blood agar plates at 37°C and stored in cryogenic vials at −80°C in brain heart infusion broth with 20% glycerol.

Reference method.

We consider the choE-based PCR to be the reference method for R. equi identification. All the strains were assayed by choE PCR, as described in detail elsewhere (9). PCR-negative choE isolates were identified by sequencing of a species-specific region of the 16S rRNA gene delimited by primers DG74 (AGGAGGTGATCCAACCGCA) and PLO6 (5′-GGTTAAGTCCCGCAACGAGCGC-3′) (19). The PCR products were sequenced using an ABI Prism 377 apparatus (Applied Biosystems, Foster City, CA, USA). Homology searches were performed with the BLAST tool at the website of the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov).

Vitek MS.

Two different extraction protocols were used for the preparation of the samples: (i) direct extraction from colonies and (ii) extraction with ethanol. For the direct colony extraction procedure, a portion of a fresh colony was directly applied as a thin film on a spot of a MALDI disposable target plate, dried, and overlaid with 1 μl of matrix and 0.6 μl of 28.9% formic acid solution (Vitek MS-FA). Upon drying, the target plate was loaded into the Vitek MS instrument for identification. For the ethanol extraction procedure, a single colony was transferred to a 1.5-ml Eppendorf tube containing 300 μl of API suspension medium (bioMérieux) and mixed thoroughly using a vortex mixer. Absolute ethanol (Merck, Darmstadt, Germany) (900 μl) was added, and the mixture was mixed thoroughly again. After centrifugation at 13,000 rpm was performed for 2 min, the supernatant was discarded and the pellet resuspended in the residual ethanol. A volume of 1 μl of the resuspended pellet was loaded on the steel target plate, dried, and overlaid with 1 μl of Vitek MS-CHCA matrix (a saturated solution of α-cyano-4-hydroxycinnamic acid [HCCA]–acetonitrile/ethanol/water [1:1:1] acidified with 3% [vol/vol] trifluoroacetic acid) and again allowed to air dry.

Each strain tested was spotted twice on the same target slide. Measurements were performed on a Vitek MS mass spectrometer (bioMérieux) according to the manufacturer's suggested settings using automatically collected spectra. Captured spectra were analyzed with Shimadzu Launchpad identification software that included the database SARAMIS MS-ID version 2.0 (Anagnos Tee GmbH). For each run, Escherichia coli ATCC 8739 was included as a standard to calibrate the instrument and to validate the run. The system reported the best identification matches along with confidence values from 0% to 100%. For a reliable identification at the species level, only hits with scores of 99.9% were accepted. Peak matches that yielded identification results with confidence values between 50% and 99.8% were considered acceptable but required confirmation by 16S rRNA sequencing. When a good identification was not obtained with the direct colony extraction method, subsequent analysis was done with the ethanol extraction method.

Bruker Biotyper.

All the strains were subjected to analysis with the system using the following procedure: the bacterial biomass was smeared onto a metallic MALDI-TOF MSP 96 plate (Bruker Daltonics) and covered with 1 μl of saturated α-cian-4-hydroxycinamic acid–50% acetonitrile–2.5% trifluoroacetic acid. The plate was dried at room temperature for 5 min. When the first attempt at identification did not give results with a high level of confidence, samples were identified using formic acid-acetonitrile extraction (20). Briefly, 2 to 3 colonies were transferred to a 1.5-ml Eppendorf tube containing 300 μl of distilled water and were then mixed with 900 μl of ethanol by pipetting. The suspension was pelleted by centrifugation at 13,000 rpm for 2 min, evaporated to dryness, and then reconstituted in 50 μl of 70% formic acid (Sigma-Aldrich, Madrid, Spain). After incubation for 30 s, 50 μl of acetonitrile (Sigma-Aldrich) was added. The suspension was then centrifuged at 13,000 rpm for 2 min. Next, 1.0 μl of the supernatant was applied to a 96-spot polished steel target plate (Bruker Daltonics) and dried. A saturated solution of 1.0 μl of MALDI matrix (α-cyano-4-hydroxycinnamic acid [HCCA]; Bruker Daltonics) was applied to each sample and dried. Measurements were performed with a Bruker Microflex LT MALDI-TOF MS system (Bruker Daltonics) using FlexControl software with Compass Flex Series version 1.3 software and a 60-Hz nitrogen laser (337-nm wavelength). The protein spectra with mass-to-charge ratios (m/z) ranging from 2,000 to 20,000 were explored with the Bruker Biotyper 3.1 software package with default settings and compared with the reference spectra present in the database, showing the 10 most similar patterns for each isolate. The database for identification was the reference Biotyper library v4.0 5,627 MSP (Bruker Daltonic), which included 5,627 species. The similarity of patterns was represented as a score (≥2.000, identification at the species level; 1.700 to 1.999, identification at the genus level; <1.700, no reliable identification). E. coli ATCC 25922 was used as a standard for calibration and as a reference for quality control.

ACKNOWLEDGMENTS

We thank Dámaso Crespo for his revision and corrections of the manuscript.

This work was supported by grants from the Institute of Health Carlos III (cofinanced by European Development Regional Fund “A way to achieve Europe”) and the Spanish Network for the Research in Infectious Diseases (REIPI RD12/0015).

We declare no conflict of interests.

REFERENCES

  • 1.Vázquez-Boland JA, Giguère S, Hapeshi A, MacArthur I, Anastasi E, Valero-Rello A. 2013. Rhodococcus equi: the many facets of a pathogenic actinomycete. Vet Microbiol 167:9–33. doi: 10.1016/j.vetmic.2013.06.016. [DOI] [PubMed] [Google Scholar]
  • 2.Yamshchikov AV, Schuetz A, Lyon GM. 2010. Rhodococcus equi infection. Lancet Infect Dis 10:350–359. doi: 10.1016/S1473-3099(10)70068-2. [DOI] [PubMed] [Google Scholar]
  • 3.Sudhindra P, Wang G, Nadelman RB. 2016. Identification of Dietzia spp. from cardiac tissue by 16S rRNA PCR in a patient with culture-negative device-associated endocarditis: a case report and review of the literature. Case Rep Infect Dis 2016:8935052. doi.10.1155/2016/8935052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Giguère S, Prescott JF. 1997. Clinical manifestations, diagnosis, treatment, and prevention of Rhodococcus equi infection in foals. Vet Microbiol 56:313–334. doi: 10.1016/S0378-1135(97)00099-0. [DOI] [PubMed] [Google Scholar]
  • 5.Funke G, Renaud FN, Freney J, Riegel P. 1997. Multicenter evaluation of the updated and extended API (RAPID) Coryne database 2.0. J Clin Microbiol 35:3122–3126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Bemer-Melchior P, Haloun A, Riegel P, Drugeon HB. 1999. Bacteremia due to Dietzia maris in an immunocompromised patient. Clin Infect Dis 29:1338–1340. doi: 10.1086/313490. [DOI] [PubMed] [Google Scholar]
  • 7.Pilares L, Agüero J, Vázquez-Boland JA, Martínez-Martínez L, Navas J. 2010. Identification of atypical Rhodococcus-like clinical isolates as Dietzia spp. by 16S rRNA gene sequencing. J Clin Microbiol 48:1904–1907. doi: 10.1128/JCM.01730-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Niwa H, Lasker BA, Hinrikson HP, Franzen CG, Steigerwalt AG, Whitney AM, Brown JM. 2012. Characterization of human clinical isolates of Dietzia species previously misidentified as Rhodococcus equi. Eur J Clin Microbiol Infect Dis 31:811–820. doi: 10.1007/s10096-011-1379-7. [DOI] [PubMed] [Google Scholar]
  • 9.Ladrón N, Fernández M, Agüero J, González Zörn B, Vázquez-Boland JA, Navas J. 2003. Rapid identification of Rhodococcus equi by a PCR assay targeting the choE gene. J Clin Microbiol 41:3241–3245. doi: 10.1128/JCM.41.7.3241-3245.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Stefańska I, Witkowski L, Rzewuska M, Dzieciątkowski T. 2016. Development and evaluation of the internal-controlled real-time PCR assay for Rhodococcus equi detection in various clinical specimens. J Vet Med Sci 78:543–549. doi: 10.1292/jvms.15-0516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Welker M. 2011. Proteomics for routine identification of microorganisms. Proteomics 11:3143–3153. doi: 10.1002/pmic.201100049. [DOI] [PubMed] [Google Scholar]
  • 12.Vila J, Juiz P, Salas C, Almela M, de la Fuente CG, Zboromyrska Y, Navas J, Bosch J, Agüero J, de la Bellacasa JP, Martínez-Martínez L. 2012. Identification of clinically relevant Corynebacterium spp., Arcanobacterium haemolyticum, and Rhodococcus equi by matrix-assisted laser desorption ionization–time of flight mass spectrometry. J Clin Microbiol 50:1745–1747. doi: 10.1128/JCM.05821-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Balada-Llasat JM, Kamboj K, Pancholi P. 2013. Identification of mycobacteria from solid and liquid media by matrix-assisted laser desorption ionization–time of flight mass spectrometry in the clinical laboratory. J Clin Microbiol 51:2875–2879. doi: 10.1128/JCM.00819-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Mather CA, Rivera SF, Butler-Wu SM. 2014. Comparison of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization–time of flight mass spectrometry systems for identification of mycobacteria using simplified protein extraction protocols. J Clin Microbiol 52:130–138. doi: 10.1128/JCM.01996-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Yassin AF, Hupfer H, Schaal KP. 2006. Dietzia cinnamea sp. nov., a novel species isolated from a perianal swab of a patient with a bone marrow transplant. Int J Syst Evol Microbiol 56:641–645. doi: 10.1099/ijs.0.63863-0. [DOI] [PubMed] [Google Scholar]
  • 16.Procópio L, Alvarez VM, Jurelevicius DA, Hansen L, Sørensen SJ, Cardoso JS, Pádula M, Leitão AC, Seldin L, van Elsas JD. 2012. Insight from the draft genome of Dietzia cinnamea P4 reveals mechanisms of survival in complex tropical soil habitats and biotechnology potential. Antonie Van Leeuwenhoek 101:289–302. doi: 10.1007/s10482-011-9633-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Dunne WM, Dolng JK, Miller E, Miller E, Moreno E, Baghli M, Mailler S, Girard V, van Belkum A, Deol P. 2014. Rapid inactivation of Mycobacterium and Nocardia species before identification using matrix-assisted laser desorption ionization–time of flight mass spectrometry. J Clin Microbiol 52:3654–3659. doi: 10.1128/JCM.01728-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Koerner RJ, Goodfellow M, Jones AL. 2009. The genus Dietzia: a new home for some known and emerging opportunistic pathogens. FEMS Immunol Med Microbiol 55:296–305. doi: 10.1111/j.1574-695X.2008.00513.x. [DOI] [PubMed] [Google Scholar]
  • 19.Greisen K, Loeffelholz M, Purohit A, Leong D. 1994. PCR primers and probes for the 16S rRNA gene of most species of pathogenic bacteria, including bacteria found in cerebrospinal fluid. J Clin Microbiol 32:335–351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Hsueh PR, Lee TF, Du SH, Teng SH, Llao CH, Sheng WH, Teng LJ. 2014. Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of Nocardia, Rhodococcus, Kocuria, Gordonia, Tsukamurella, and Listeria species. J Clin Microbiol 52:2371–2379. doi: 10.1128/JCM.00456-14. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES